Biohaven (BHVN) Total Non-Current Liabilities (2021 - 2026)

Biohaven (BHVN) posted Total Non-Current Liabilities of $332.3 million for Q1 2026, down 15.82% sequentially from $394.8 million in Q4 2025, and up 199.06% YoY from $111.1 million in Q1 2025.

Biohaven (BHVN) Total Non-Current Liabilities (2021 - 2026) Analysis & Trends

Biohaven has reported Total Non-Current Liabilities for 6 years, with the latest figure at $332.3 million in Q1 2026.

  • Quarterly Total Non-Current Liabilities rose 199.06% year-over-year to $332.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $332.3 million (up 199.06% YoY) and the FY2025 annual result came in at $394.8 million, up 111.11% from the prior year.
  • Total Non-Current Liabilities slipped to $332.3 million in Q1 2026 per BHVN's latest filing, from $394.8 million in the prior quarter.
  • Over five years, Total Non-Current Liabilities peaked at $394.8 million in Q4 2025 and troughed at $28.4 million in Q3 2022.
  • A 5-year average of $161.6 million and a median of $143.8 million in 2023 frame the typical range for Total Non-Current Liabilities.
  • The widest YoY moves for Total Non-Current Liabilities: up 218.14% in 2023, down 31.19% in 2023.
  • Over 5 years, Total Non-Current Liabilities stood at $120.6 million in 2022, then sank by 31.19% to $83.0 million in 2023, then jumped by 125.33% to $187.0 million in 2024, then jumped by 111.11% to $394.8 million in 2025, then decreased by 15.82% to $332.3 million in 2026.
  • According to Business Quant data, Total Non-Current Liabilities over the past three periods registered $332.3 million, $394.8 million, and $158.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn 5.92 Bn
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn 7.74 Bn
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn 40.00 Mn
4 Revolution Medicines 43.64 Bn 43.64 Bn - 1.53 Bn
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn 1.88 Bn
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn -
7 Royalty Pharma 33.72 Bn 35.84 Bn - 9.32 Bn
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn 4.20 Bn
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn 1.17 Bn
10 Biohaven 2.21 Bn 1.94 Bn - 355.03 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 355.03 Mn
Mar 31, 2026 332.35 Mn
Dec 31, 2025 394.79 Mn
Sep 30, 2025 158.01 Mn
Jun 30, 2025 158.76 Mn
Mar 31, 2025 111.13 Mn
Dec 31, 2024 187.01 Mn
Sep 30, 2024 189.93 Mn
Jun 30, 2024 194.58 Mn
Mar 31, 2024 113.67 Mn
Dec 31, 2023 82.99 Mn
Sep 30, 2023 90.46 Mn
Jun 30, 2023 116.96 Mn
Mar 31, 2023 143.77 Mn
Dec 31, 2022 120.60 Mn
Sep 30, 2022 28.44 Mn
Dec 31, 2021 44.73 Mn